{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:24:06Z","timestamp":1775301846705,"version":"3.50.1"},"reference-count":0,"publisher":"Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada","issue":"11\/12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Promot Chronic Dis Prev Can"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<sec>\n         <title>Abstract<\/title>\n         <p>As the effects of COVID-19 have been unfolding, growing attention has been paid to the intersection of COVID-19 and substance use and the related harms. However, there are few theories and little empirical evidence to guide investigations in this area. To advance this emerging area of inquiry, we present a conceptual model that synthesizes evidence, information and knowledge on substance use and related harms in the context of the pandemic. The conceptual model offers a visual representation of the connections between the pandemic and substance use and related harms, and can be used to identify areas for future research.<\/p>\n       <\/sec>","DOI":"10.24095\/hpcdp.40.11\/12.03","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T12:29:29Z","timestamp":1600259369000},"page":"342-349","source":"Crossref","is-referenced-by-count":27,"title":["Substance use and related harms in the context of COVID-19: a conceptual model"],"prefix":"10.24095","volume":"40","author":[{"given":"Aganeta","family":"Enns","sequence":"first","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adena","family":"Pinto","sequence":"additional","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeyasakthi","family":"Venugopal","sequence":"additional","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Grywacheski","sequence":"additional","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Gheorghe","sequence":"additional","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Kakkar","sequence":"additional","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noushon","family":"Farmanara","sequence":"additional","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhumika","family":"Deb","sequence":"additional","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Noon","sequence":"additional","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Orpana","sequence":"additional","affiliation":[{"name":"Substance Related Harms Division, Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10188","container-title":["Health Promotion and Chronic Disease Prevention in Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/en\/public-health\/services\/reports-publications\/health-promotion-chronic-disease-prevention-canada-research-policy-practice\/vol-40-no-11-12-2020\/substance-use-related-harms-covid-19-conceptual-model.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T13:04:56Z","timestamp":1607346296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/en\/public-health\/services\/reports-publications\/health-promotion-chronic-disease-prevention-canada-research-policy-practice\/vol-40-no-11-12-2020\/substance-use-related-harms-covid-19-conceptual-model.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":0,"journal-issue":{"issue":"11\/12"},"URL":"https:\/\/doi.org\/10.24095\/hpcdp.40.11\/12.03","archive":["Internet Archive"],"relation":{},"ISSN":["2368-738X"],"issn-type":[{"value":"2368-738X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}